{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T03:01:28Z","timestamp":1780628488001,"version":"3.54.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Mol and Cell Biol"],"DOI":"10.1186\/s12860-026-00576-w","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T07:14:33Z","timestamp":1776928473000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunomodulatory effects of TAK-242 on osteogenesis of mesenchymal stem cells in acute inflammatory conditions"],"prefix":"10.1186","volume":"27","author":[{"given":"Mahsa","family":"Ghiasvand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam Talebi","family":"Jouybari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood","family":"Talkhabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Taghiyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,23]]},"reference":[{"key":"576_CR1","doi-asserted-by":"publisher","first-page":"121114","DOI":"10.1016\/j.biomaterials.2021.121114","volume":"277","author":"H Newman","year":"2021","unstructured":"Newman H, Shih YV, Varghese S. Resolution of inflammation in bone regeneration: from Understandings to therapeutic applications. Biomaterials. 2021;277:121114.","journal-title":"Biomaterials"},{"issue":"1","key":"576_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s41232-023-00279-1","volume":"43","author":"J Kushioka","year":"2023","unstructured":"Kushioka J, Chow SK-H, Toya M, Tsubosaka M, Shen H, Gao Q, et al. Bone regeneration in inflammation with aging and cell-based Immunomodulatory therapy. Inflamm Regeneration. 2023;43(1):29.","journal-title":"Inflamm Regeneration"},{"key":"576_CR3","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3389\/fphys.2018.00504","volume":"9","author":"A Alonso-P\u00e9rez","year":"2018","unstructured":"Alonso-P\u00e9rez A, Franco-Trepat E, Guill\u00e1n-Fresco M, Jorge-Mora A, L\u00f3pez V, Pino J, et al. Role of toll-like receptor 4 on osteoblast metabolism and function. Front Physiol. 2018;9:504.","journal-title":"Front Physiol"},{"issue":"3","key":"576_CR4","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1677\/JOE-08-0568","volume":"201","author":"R Hardy","year":"2009","unstructured":"Hardy R, Cooper M. Bone loss in inflammatory disorders. J Endocrinol. 2009;201(3):309\u201320.","journal-title":"J Endocrinol"},{"issue":"16","key":"576_CR5","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.7150\/ijms.61080","volume":"18","author":"N Yang","year":"2021","unstructured":"Yang N, Liu Y. The role of the immune microenvironment in bone regeneration. Int J Med Sci. 2021;18(16):3697.","journal-title":"Int J Med Sci"},{"issue":"11\u201312","key":"576_CR6","doi-asserted-by":"publisher","first-page":"4385","DOI":"10.1111\/j.1582-4934.2009.00857.x","volume":"13","author":"NK Satija","year":"2009","unstructured":"Satija NK, Singh VK, Verma YK, Gupta P, Sharma S, Afrin F, et al. Mesenchymal stem cell-based therapy: a new paradigm in regenerative medicine. J Cell Mol Med. 2009;13(11\u201312):4385\u2013402.","journal-title":"J Cell Mol Med"},{"key":"576_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.biomaterials.2017.10.046","volume":"196","author":"B-D Sui","year":"2019","unstructured":"Sui B-D, Hu C-H, Liu A-Q, Zheng C-X, Xuan K, Jin Y. Stem cell-based bone regeneration in diseased microenvironments: challenges and solutions. Biomaterials. 2019;196:18\u201330.","journal-title":"Biomaterials"},{"key":"576_CR8","doi-asserted-by":"crossref","unstructured":"Roh JS, Sohn DH. Damage-associated molecular patterns in inflammatory diseases. Immune Netw. 2018;18(4).","DOI":"10.4110\/in.2018.18.e27"},{"issue":"4","key":"576_CR9","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","volume":"124","author":"S Akira","year":"2006","unstructured":"Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124(4):783\u2013801.","journal-title":"Cell"},{"issue":"1","key":"576_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s42269-019-0227-2","volume":"43","author":"SR El-Zayat","year":"2019","unstructured":"El-Zayat SR, Sibaii H, Mannaa FA. Toll-like receptors activation, signaling, and targeting: an overview. Bull Natl Res Centre. 2019;43(1):1\u201312.","journal-title":"Bull Natl Res Centre"},{"issue":"3","key":"576_CR11","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nrrheum.2014.209","volume":"11","author":"R G\u00f3mez","year":"2015","unstructured":"G\u00f3mez R, Villalvilla A, Largo R, Gualillo O, Herrero-Beaumont G. TLR4 signalling in osteoarthritis\u2014finding targets for candidate DMOADs. Nat Rev Rheumatol. 2015;11(3):159\u201370.","journal-title":"Nat Rev Rheumatol"},{"key":"576_CR12","doi-asserted-by":"publisher","first-page":"1333086","DOI":"10.3389\/fimmu.2024.1333086","volume":"15","author":"X Zhu","year":"2024","unstructured":"Zhu X, Du L, Zhang L, Ding L, Xu W, Lin X. The critical role of toll-like receptor 4 in bone remodeling of osteoporosis: from inflammation recognition to immunity. Front Immunol. 2024;15:1333086.","journal-title":"Front Immunol"},{"issue":"2","key":"576_CR13","doi-asserted-by":"publisher","first-page":"113612","DOI":"10.1016\/j.yexcr.2023.113612","volume":"427","author":"Z Huang","year":"2023","unstructured":"Huang Z, Chen G, Wu H, Huang X, Xu R, Deng F, et al. Ebselen restores peri-implantitis-induced osteogenic Inhibition via suppressing BMSCs ferroptosis. Exp Cell Res. 2023;427(2):113612.","journal-title":"Exp Cell Res"},{"issue":"3","key":"576_CR14","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.3390\/ijms22031169","volume":"22","author":"Y Chang","year":"2021","unstructured":"Chang Y, Hu C-C, Wu Y-Y, Ueng SWN, Chang C-H, Chen M-F. Ibudilast mitigates delayed bone healing caused by lipopolysaccharide by altering osteoblast and osteoclast activity. Int J Mol Sci. 2021;22(3):1169.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"576_CR15","first-page":"1569","volume":"22","author":"MX Xu","year":"2018","unstructured":"Xu MX, Sun XX, Li W, Xie G, Yang Q, Qu ZW, et al. LPS at low concentration promotes the fracture healing through regulating the autophagy of osteoblasts via NF-\u03baB signal pathway. Eur Rev Med Pharmacol Sci. 2018;22(6):1569\u201379.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"576_CR16","doi-asserted-by":"crossref","unstructured":"Lv D, Li B, Liu Z, Zhang Q, Cao S, Xu Y et al. LPS\u2013mediated adaptation accelerates ecto\u2013MSCs differentiation into osteoblasts. Mol Med Rep. 2024;30(6).","DOI":"10.3892\/mmr.2024.13365"},{"key":"576_CR17","doi-asserted-by":"crossref","unstructured":"Choppa VSR, Liu G, Tompkins YH, Kim WK. Altered osteogenic differentiation in mesenchymal stem cells isolated from compact bone of chicken treated with varying doses of lipopolysaccharides. Biomolecules. 2023;13(11).","DOI":"10.3390\/biom13111626"},{"issue":"3","key":"576_CR18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/scrt456","volume":"5","author":"C Li","year":"2014","unstructured":"Li C, Li B, Dong Z, Gao L, He X, Liao L, et al. Lipopolysaccharide differentially affects the osteogenic differentiation of periodontal ligament stem cells and bone marrow mesenchymal stem cells through Toll-like receptor 4 mediated nuclear factor \u03baB pathway. Stem Cell Res Ther. 2014;5(3):67.","journal-title":"Stem Cell Res Ther"},{"key":"576_CR19","doi-asserted-by":"publisher","first-page":"112681","DOI":"10.3389\/fimmu.2014.00461","volume":"5","author":"T Kawasaki","year":"2014","unstructured":"Kawasaki T, Kawai T. Toll-like receptor signaling pathways. Front Immunol. 2014;5:112681.","journal-title":"Front Immunol"},{"key":"576_CR20","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1007\/s12272-016-0806-9","volume":"39","author":"A Achek","year":"2016","unstructured":"Achek A, Yesudhas D, Choi S. Toll-like receptors: promising therapeutic targets for inflammatory diseases. Arch Pharm Res. 2016;39:1032\u201349.","journal-title":"Arch Pharm Res"},{"issue":"2","key":"576_CR21","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.cyto.2008.01.006","volume":"42","author":"Y-C Lu","year":"2008","unstructured":"Lu Y-C, Yeh W-C, Ohashi PS. LPS\/TLR4 signal transduction pathway. Cytokine. 2008;42(2):145\u201351.","journal-title":"Cytokine"},{"issue":"4","key":"576_CR22","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1124\/mol.105.019695","volume":"69","author":"M Ii","year":"2006","unstructured":"Ii M, Matsunaga N, Hazeki K, Nakamura K, Takashima K, Seya T, et al. A novel cyclohexene derivative, Ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl) sulfamoyl] cyclohex-1-ene-1-carboxylate (TAK-242), selectively inhibits toll-like receptor 4-mediated cytokine production through suppression of intracellular signaling. Mol Pharmacol. 2006;69(4):1288\u201395.","journal-title":"Mol Pharmacol"},{"issue":"8","key":"576_CR23","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1097\/CCM.0b013e3181e7c5c9","volume":"38","author":"TW Rice","year":"2010","unstructured":"Rice TW, Wheeler AP, Bernard GR, Vincent J-L, Angus DC, Aikawa N, et al. A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis. Crit Care Med. 2010;38(8):1685\u201394.","journal-title":"Crit Care Med"},{"issue":"11","key":"576_CR24","doi-asserted-by":"publisher","first-page":"5138","DOI":"10.1111\/jcmm.16506","volume":"25","author":"F Khodabandehloo","year":"2021","unstructured":"Khodabandehloo F, Aflatoonian R, Zandieh Z, Rajaei F, Sayahpour FA, Nassiri-Asl M, et al. Functional differences of Toll\u2010like receptor 4 in osteogenesis, adipogenesis and chondrogenesis in human bone marrow\u2010derived mesenchymal stem cells. J Cell Mol Med. 2021;25(11):5138\u201349.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"576_CR25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.7150\/ijms.58428","volume":"19","author":"F Gu","year":"2022","unstructured":"Gu F, Zhang K, Li J, Xie X, Wen Q, Sui Z, et al. Changes of migration, immunoregulation and osteogenic differentiation of mesenchymal stem cells in different stages of inflammation. Int J Med Sci. 2022;19(1):25.","journal-title":"Int J Med Sci"},{"key":"576_CR26","doi-asserted-by":"crossref","unstructured":"Kareem R, Botleroo RA, Bhandari R, Ogeyingbo OD, Ahmed R, Gyawali M et al. The impact of rheumatoid arthritis on bone loss: links to osteoporosis and osteopenia. Cureus. 2021;13(8).","DOI":"10.7759\/cureus.17519"},{"issue":"6","key":"576_CR27","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nrrheum.2016.61","volume":"12","author":"LA Joosten","year":"2016","unstructured":"Joosten LA, Abdollahi-Roodsaz S, Dinarello CA, O\u2019neill L, Netea MG. Toll-like receptors and chronic inflammation in rheumatic diseases: new developments. Nat Rev Rheumatol. 2016;12(6):344\u201357.","journal-title":"Nat Rev Rheumatol"},{"key":"576_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-020-2097-2","volume":"22","author":"S Samarpita","year":"2020","unstructured":"Samarpita S, Kim JY, Rasool MK, Kim KS. Investigation of toll-like receptor (TLR) 4 inhibitor TAK-242 as a new potential anti-rheumatoid arthritis drug. Arthritis Res Therapy. 2020;22:1\u201310.","journal-title":"Arthritis Res Therapy"},{"issue":"1","key":"576_CR29","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1634\/stemcells.2007-0454","volume":"26","author":"F Liotta","year":"2008","unstructured":"Liotta F, Angeli R, Cosmi L, Fil\u00ec L, Manuelli C, Frosali F, et al. Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling. Stem Cells. 2008;26(1):279\u201389.","journal-title":"Stem Cells"},{"issue":"6","key":"576_CR30","doi-asserted-by":"publisher","first-page":"e12516","DOI":"10.1111\/cpr.12516","volume":"51","author":"L Shang","year":"2018","unstructured":"Shang L, Wang T, Tong D, Kang W, Liang Q, Ge S. Prolyl hydroxylases positively regulated LPS-induced inflammation in human gingival fibroblasts via TLR4\/MyD88\u2010mediated AKT\/NF\u2010\u03baB and MAPK pathways. Cell Prolif. 2018;51(6):e12516.","journal-title":"Cell Prolif"},{"key":"576_CR31","doi-asserted-by":"publisher","first-page":"1013159","DOI":"10.3389\/fimmu.2022.1013159","volume":"13","author":"Z Wen","year":"2022","unstructured":"Wen Z, Zhang Y, Feng J, Aimulajiang K, Aleem MT, Lu M, et al. Excretory\/secretory proteins inhibit host immune responses by downregulating the TLR4\/NF-\u03baB\/MAPKs signaling pathway: A possible mechanism of immune evasion in parasitic nematode Haemonchus contortus. Front Immunol. 2022;13:1013159.","journal-title":"Front Immunol"},{"issue":"3","key":"576_CR32","doi-asserted-by":"publisher","first-page":"e0149876","DOI":"10.1371\/journal.pone.0149876","volume":"11","author":"X He","year":"2016","unstructured":"He X, Wang H, Jin T, Xu Y, Mei L, Yang J. TLR4 activation promotes bone marrow MSC proliferation and osteogenic differentiation via Wnt3a and Wnt5a signaling. PLoS ONE. 2016;11(3):e0149876.","journal-title":"PLoS ONE"},{"issue":"1","key":"576_CR33","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1634\/stemcells.2007-0563","volume":"26","author":"SL Tomchuck","year":"2008","unstructured":"Tomchuck SL, Zwezdaryk KJ, Coffelt SB, Waterman RS, Danka ES, Scandurro AB. Toll-like receptors on human mesenchymal stem cells drive their migration and Immunomodulating responses. Stem Cells. 2008;26(1):99\u2013107.","journal-title":"Stem Cells"},{"issue":"12","key":"576_CR34","doi-asserted-by":"publisher","first-page":"7963","DOI":"10.4049\/jimmunol.0803864","volume":"182","author":"R Romieu-Mourez","year":"2009","unstructured":"Romieu-Mourez R, Fran\u00e7ois M, Boivin M-N, Bouchentouf M, Spaner DE, Galipeau J. Cytokine modulation of TLR expression and activation in mesenchymal stromal cells leads to a Proinflammatory phenotype. J Immunol. 2009;182(12):7963\u201373.","journal-title":"J Immunol"},{"issue":"1","key":"576_CR35","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.biotechadv.2011.05.014","volume":"30","author":"F Peri","year":"2012","unstructured":"Peri F, Piazza M. Therapeutic targeting of innate immunity with Toll-like receptor 4 (TLR4) antagonists. Biotechnol Adv. 2012;30(1):251\u201360.","journal-title":"Biotechnol Adv"},{"issue":"2\u20133","key":"576_CR36","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.toxlet.2009.08.025","volume":"191","author":"TT Wu","year":"2009","unstructured":"Wu TT, Chen TL, Chen RM. Lipopolysaccharide triggers macrophage activation of inflammatory cytokine expression, chemotaxis, phagocytosis, and oxidative ability via a toll-like receptor 4-dependent pathway: validated by RNA interference. Toxicol Lett. 2009;191(2\u20133):195\u2013202.","journal-title":"Toxicol Lett"},{"issue":"14","key":"576_CR37","doi-asserted-by":"publisher","first-page":"6495","DOI":"10.1021\/acs.jmedchem.9b00061","volume":"62","author":"A Achek","year":"2019","unstructured":"Achek A, Shah M, Seo JY, Kwon H-K, Gui X, Shin H-J, et al. Linear and rationally designed stapled peptides abrogate TLR4 pathway and relieve inflammatory symptoms in rheumatoid arthritis rat model. J Med Chem. 2019;62(14):6495\u2013511.","journal-title":"J Med Chem"},{"issue":"20","key":"576_CR38","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.3390\/molecules24203731","volume":"24","author":"S Ye","year":"2019","unstructured":"Ye S, Zheng Q, Zhou Y, Bai B, Yang D, Zhao Z. Chlojaponilactone B attenuates lipopolysaccharide-induced inflammatory responses by suppressing TLR4-mediated ROS generation and NF-\u03baB signaling pathway. Molecules. 2019;24(20):3731.","journal-title":"Molecules"},{"issue":"1","key":"576_CR39","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/imr.12671","volume":"285","author":"JM Cicchese","year":"2018","unstructured":"Cicchese JM, Evans S, Hult C, Joslyn LR, Wessler T, Millar JA, et al. Dynamic balance of pro-and anti\u2010inflammatory signals controls disease and limits pathology. Immunol Rev. 2018;285(1):147\u201367.","journal-title":"Immunol Rev"},{"key":"576_CR40","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s42358-024-00385-9","volume":"64","author":"M Khomeijani-Farahani","year":"2024","unstructured":"Khomeijani-Farahani M, Karami J, Farhadi E, Soltani S, Delbandi A-A, Shekarabi M, et al. TAK-242 (Resatorvid) inhibits Proinflammatory cytokine production through the Inhibition of NF-\u03baB signaling pathway in fibroblast-like synoviocytes in osteoarthritis patients. Adv Rheumatol. 2024;64:46.","journal-title":"Adv Rheumatol"},{"key":"576_CR41","doi-asserted-by":"publisher","first-page":"1277686","DOI":"10.3389\/fcell.2023.1277686","volume":"11","author":"X Liu","year":"2023","unstructured":"Liu X, Zhou Z, Zeng W-N, Zeng Q, Zhang X. The role of toll-like receptors in orchestrating osteogenic differentiation of mesenchymal stromal cells and osteoimmunology. Front Cell Dev Biology. 2023;11:1277686.","journal-title":"Front Cell Dev Biology"},{"issue":"4","key":"576_CR42","doi-asserted-by":"publisher","first-page":"e10088","DOI":"10.1371\/journal.pone.0010088","volume":"5","author":"RS Waterman","year":"2010","unstructured":"Waterman RS, Tomchuck SL, Henkle SL, Betancourt AM. A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an immunosuppressive MSC2 phenotype. PLoS ONE. 2010;5(4):e10088.","journal-title":"PLoS ONE"},{"issue":"12","key":"576_CR43","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1634\/stemcells.2006-0189","volume":"24","author":"H Hwa Cho","year":"2006","unstructured":"Hwa Cho H, Bae YC, Jung JS. Role of toll-like receptors on human adipose\u2010derived stromal cells. Stem Cells. 2006;24(12):2744\u201352.","journal-title":"Stem Cells"},{"issue":"7","key":"576_CR44","doi-asserted-by":"publisher","first-page":"e0132781","DOI":"10.1371\/journal.pone.0132781","volume":"10","author":"M Croes","year":"2015","unstructured":"Croes M, Oner FC, Kruyt MC, Blokhuis TJ, Bastian O, Dhert WJ, et al. Proinflammatory mediators enhance the osteogenesis of human mesenchymal stem cells after lineage commitment. PLoS ONE. 2015;10(7):e0132781.","journal-title":"PLoS ONE"},{"issue":"6","key":"576_CR45","first-page":"2341","volume":"43","author":"B Yu","year":"2019","unstructured":"Yu B, Li Q, Zhou M. LPS\u2013induced upregulation of the TLR4 signaling pathway inhibits osteogenic differentiation of human periodontal ligament stem cells under inflammatory conditions. Int J Mol Med. 2019;43(6):2341\u201351.","journal-title":"Int J Mol Med"},{"issue":"6","key":"576_CR46","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.joca.2008.11.011","volume":"17","author":"D Lacey","year":"2009","unstructured":"Lacey D, Simmons P, Graves S, Hamilton J. Proinflammatory cytokines inhibit osteogenic differentiation from stem cells: implications for bone repair during inflammation. Osteoarthr Cartil. 2009;17(6):735\u201342.","journal-title":"Osteoarthr Cartil"},{"key":"576_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/scrt492","volume":"5","author":"CB Sullivan","year":"2014","unstructured":"Sullivan CB, Porter RM, Evans CH, Ritter T, Shaw G, Barry F, et al. TNF\u03b1 and IL-1\u03b2 influence the differentiation and migration of murine MSCs independently of the NF-\u03baB pathway. Stem Cell Res Ther. 2014;5:1\u201313.","journal-title":"Stem Cell Res Ther"},{"key":"576_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/scrt456","volume":"5","author":"C Li","year":"2014","unstructured":"Li C, Li B, Dong Z, Gao L, He X, Liao L, et al. Lipopolysaccharide differentially affects the osteogenic differentiation of periodontal ligament stem cells and bone marrow mesenchymal stem cells through Toll-like receptor 4 mediated nuclear factor \u03baB pathway. Stem Cell Res Ther. 2014;5:1\u201313.","journal-title":"Stem Cell Res Ther"},{"key":"576_CR49","doi-asserted-by":"publisher","first-page":"634650","DOI":"10.3389\/fcell.2021.634650","volume":"9","author":"S Chen","year":"2021","unstructured":"Chen S, Liang H, Ji Y, Kou H, Zhang C, Shang G, et al. Curcumin modulates the crosstalk between macrophages and bone mesenchymal stem cells to ameliorate osteogenesis. Front Cell Dev Biology. 2021;9:634650.","journal-title":"Front Cell Dev Biology"},{"issue":"1","key":"576_CR50","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.yexcr.2016.11.012","volume":"350","author":"N Herzmann","year":"2017","unstructured":"Herzmann N, Salamon A, Fiedler T, Peters K. Lipopolysaccharide induces proliferation and osteogenic differentiation of adipose-derived mesenchymal stromal cells in vitro via TLR4 activation. Exp Cell Res. 2017;350(1):115\u201322.","journal-title":"Exp Cell Res"},{"issue":"4","key":"576_CR51","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1111\/jre.12877","volume":"56","author":"X Yang","year":"2021","unstructured":"Yang X, Tao X, Qi W, Liu Z, Wang Y, Han Q, et al. TLR-4 targeting contributes to the recovery of osteoimmunology in periodontitis. J Periodontal Res. 2021;56(4):782\u20138.","journal-title":"J Periodontal Res"},{"key":"576_CR52","doi-asserted-by":"crossref","unstructured":"Chen Q, Tang X, Cao X, Meng C, Shen P. TLR-2\/4 Inhibition accelerates bone repair via modulating MyD88\/NF-\u03baB signaling and inflammatory microenvironment. Biochem Biophys Res Commun. 2025:152994.","DOI":"10.1016\/j.bbrc.2025.152994"}],"container-title":["BMC Molecular and Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12860-026-00576-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12860-026-00576-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12860-026-00576-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T02:02:21Z","timestamp":1780624941000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12860-026-00576-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,23]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["576"],"URL":"https:\/\/doi.org\/10.1186\/s12860-026-00576-w","relation":{},"ISSN":["2661-8850"],"issn-type":[{"value":"2661-8850","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,23]]},"assertion":[{"value":"20 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted with contributions from Shahid Beheshti University and Royan Institute and received approval from the local ethics committee of the Royan Institute (IR.ACECR.AEC.1402.033).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32"}}